Director
Bristol Myers Squibb
Bridgewater, New Jersey
Carl Allenspach is a pharmaceutical leader with over 25 years in drug development, manufacturing, and business operations and has contributed to over 45 compounds at Pfizer, Novartis, and Bristol Myers Squibb. He has extensive experience across early and late stage development, global filings, and manufacturing support. An active AAPS member since 2010, Carl has chaired scientific programming and other committees and was recently elected to the board of directors. He holds a Ph.D. in Pharmaceutical Science from Rutgers University and is recognized for his leadership, innovation, and commitment to mentoring and helping teams succeed.
Disclosure information not submitted.
Symposium: Navigating the Complexities of Novel Modalities and Delivery Systems 1
Tuesday, November 11, 2025
9:00 AM - 11:00 AM CT
Keynote: Pharmaceutical Novel Modalities: Opportunities and Challenges
Tuesday, November 11, 2025
1:30 PM - 2:30 PM CT
The Changing Landscape of the Pharmaceutical Industry
Tuesday, November 11, 2025
1:30 PM - 2:30 PM CT
Tuesday, November 11, 2025
2:30 PM - 3:25 PM CT